Vaccines for pneumonia and new antiviral therapies.
Influenza and pneumococcal diseases are preventable to a large extent. The Health Care Financing Agency of Medicare and the Joint Commission on Accreditation of Healthcare Organizations have made prevention of these two diseases a top priority. Immunization should remain the primary tool for prevention. When influenza epidemics appear, practitioners should be aware that effective drugs are available to treat influenza A or B if given promptly after the onset of illness.
Gross
P A
PA
Department of Internal Medicine, Hackensack University Medical Center, Hackensack, New Jersey, USA. pgross237@aol.com
D000081:Acetamides / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000547:Amantadine / Q000627:therapeutic use; D000998:Antiviral Agents / Q000009:adverse effects / Q000627:therapeutic use*; D014487:Centers for Medicare and Medicaid Services, U.S.; D002648:Child; D014943:Global Health; D006146:Guanidines; D006292:Health Priorities; D006801:Humans; D015994:Incidence; D007252:Influenza Vaccines; D007591:Joint Commission on Accreditation of Healthcare Organizations; D009017:Morbidity; D009439:Neuraminidase / Q000037:antagonists & inhibitors; D053139:Oseltamivir; D018579:Patient Selection; D022242:Pneumococcal Vaccines; D011014:Pneumonia / Q000453:epidemiology / Q000276:immunology / Q000517:prevention & control*; D011322:Primary Prevention / Q000379:methods; D011714:Pyrans; D012299:Rimantadine / Q000627:therapeutic use; D012449:Safety; D012794:Sialic Acids / Q000627:therapeutic use; D014481:United States / Q000453:epidemiology; D014611:Vaccination / Q000009:adverse effects / Q000379:methods*; D053243:Zanamivir
D000081:Acetamides; D000998:Antiviral Agents; D006146:Guanidines; D007252:Influenza Vaccines; D022242:Pneumococcal Vaccines; D011714:Pyrans; D012794:Sialic Acids; D012299:Rimantadine; D053139:Oseltamivir; D000547:Amantadine; D009439:Neuraminidase; D053243:Zanamivir